These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33843921)

  • 1. Highlights in Hodgkin lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 7(2):1-24. PubMed ID: 33843921
    [No Abstract]   [Full Text] [Related]  

  • 2. Highlights in Hodgkin lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Evens AM
    Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 7(2):20-23. PubMed ID: 33843922
    [No Abstract]   [Full Text] [Related]  

  • 3. Highlights in Hodgkin lymphoma from the 61st American Society of Hematology Annual Meeting.
    Clin Adv Hematol Oncol; 2020 Feb; 18 Suppl 6(2):1-24. PubMed ID: 33843909
    [No Abstract]   [Full Text] [Related]  

  • 4. Highlights in Hodgkin lymphoma from the 61st American Society of Hematology Annual Meeting: commentary.
    Straus DJ
    Clin Adv Hematol Oncol; 2020 Feb; 18 Suppl 6(2):20-23. PubMed ID: 33843910
    [No Abstract]   [Full Text] [Related]  

  • 5. Highlights in leukemia and lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2021 Mar; 19 Suppl 11(3):1-20. PubMed ID: 33843915
    [No Abstract]   [Full Text] [Related]  

  • 6. Highlights in leukemia and lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Barr PM
    Clin Adv Hematol Oncol; 2021 Mar; 19 Suppl 11(3):17-19. PubMed ID: 33843916
    [No Abstract]   [Full Text] [Related]  

  • 7. Highlights in relapsed/refractory follicular lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 2(1):1-20. PubMed ID: 33843857
    [No Abstract]   [Full Text] [Related]  

  • 8. Highlights in relapsed/refractory follicular lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Salles G
    Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 2(1):13-16. PubMed ID: 33843858
    [No Abstract]   [Full Text] [Related]  

  • 9. Highlights in myelodysplastic syndromes from the 62nd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 5(1):1-24. PubMed ID: 33843865
    [No Abstract]   [Full Text] [Related]  

  • 10. Highlights in myelodysplastic syndromes from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Garcia-Manero G
    Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 5(1):20-23. PubMed ID: 33843866
    [No Abstract]   [Full Text] [Related]  

  • 11. Highlights in graft-vs-host disease from the 62nd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 8(2):1-24. PubMed ID: 33843913
    [No Abstract]   [Full Text] [Related]  

  • 12. Highlights in CAR T-cell therapy from the 62nd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2021 Mar; 19 Suppl 10(3):1-24. PubMed ID: 33843917
    [No Abstract]   [Full Text] [Related]  

  • 13. Highlights in CAR T-cell therapy from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Jacobson CA
    Clin Adv Hematol Oncol; 2021 Mar; 19 Suppl 10(3):19-23. PubMed ID: 33843918
    [No Abstract]   [Full Text] [Related]  

  • 14. Highlights in chronic graft-vs-host disease from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    DiPersio JF
    Clin Adv Hematol Oncol; 2021 Feb; 19 Suppl 8(2):20-23. PubMed ID: 33843914
    [No Abstract]   [Full Text] [Related]  

  • 15. Highlights in chronic lymphocytic leukemia from the 62nd American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 4(1):1-24. PubMed ID: 33843887
    [No Abstract]   [Full Text] [Related]  

  • 16. Highlights in chronic lymphocytic leukemia from the 62nd American Society of Hematology Annual Meeting and Exposition: commentary.
    Davids MS
    Clin Adv Hematol Oncol; 2021 Jan; 19 Suppl 4(1):21-23. PubMed ID: 33843888
    [No Abstract]   [Full Text] [Related]  

  • 17. Highlights in chronic lymphocytic leukemia from the 61st American Society of Hematology Annual Meeting and Exposition.
    Clin Adv Hematol Oncol; 2020 Jan; 18 Suppl 3(1):1-20. PubMed ID: 33843855
    [No Abstract]   [Full Text] [Related]  

  • 18. Highlights in chronic lymphocytic leukemia from the 61st American Society of Hematology Annual Meeting and Exposition: commentary.
    Awan FT
    Clin Adv Hematol Oncol; 2020 Jan; 18 Suppl 3(1):14-17. PubMed ID: 33843856
    [No Abstract]   [Full Text] [Related]  

  • 19. Meeting highlights 46th annual meeting of the American Society of Hematology December 2004 San Diego, California.
    Price N; Reddy GK; Jain VK
    Clin Lymphoma; 2004 Dec; 5(3):144-8. PubMed ID: 15636687
    [No Abstract]   [Full Text] [Related]  

  • 20. 42nd Annual Meeting of American Society of Hematology. San Francisco, CA. December 1-5, 2000.
    D'Orazio AI; Gambill BD
    Clin Lymphoma; 2001 Mar; 1(4):251-6. PubMed ID: 11715982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.